Your browser doesn't support javascript.
loading
A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection.
Monaghan, Tanya M; Duggal, Niharika A; Rosati, Elisa; Griffin, Ruth; Hughes, Jamie; Roach, Brandi; Yang, David Y; Wang, Christopher; Wong, Karen; Saxinger, Lynora; Pucic-Bakovic, Maja; Vuckovic, Frano; Klicek, Filip; Lauc, Gordan; Tighe, Paddy; Mullish, Benjamin H; Blanco, Jesus Miguens; McDonald, Julie A K; Marchesi, Julian R; Xue, Ning; Dottorini, Tania; Acharjee, Animesh; Franke, Andre; Li, Yingrui; Wong, Gane Ka-Shu; Polytarchou, Christos; Yau, Tung On; Christodoulou, Niki; Hatziapostolou, Maria; Wang, Minkun; Russell, Lindsey A; Kao, Dina H.
Afiliação
  • Monaghan TM; NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham NG7 2UH, UK.
  • Duggal NA; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
  • Rosati E; MRC-Arthritis Research UK Centre for Musculoskeletal Ageing Research, Institute of Inflammation and Ageing, University of Birmingham, Birmingham B15 2TT, UK.
  • Griffin R; Institute of Clinical Molecular Biology, Universitätsklinikum Schleswig-Holstein, Christian-Albrecht University of Kiel, 24105 Kiel, Germany.
  • Hughes J; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UK.
  • Roach B; Synthetic Biology Research Centre, The University of Nottingham Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
  • Yang DY; Synthetic Biology Research Centre, The University of Nottingham Biodiscovery Institute, University of Nottingham, Nottingham NG7 2RD, UK.
  • Wang C; Division of Gastroenterology, Department of Medicine, University of Alberta; Edmonton, Alberta, AB T6G 2G3, Canada.
  • Wong K; Division of Gastroenterology, Department of Medicine, University of Alberta; Edmonton, Alberta, AB T6G 2G3, Canada.
  • Saxinger L; Division of Gastroenterology, Department of Medicine, University of Alberta; Edmonton, Alberta, AB T6G 2G3, Canada.
  • Pucic-Bakovic M; Division of Gastroenterology, Department of Medicine, University of Alberta; Edmonton, Alberta, AB T6G 2G3, Canada.
  • Vuckovic F; Division of Infectious Diseases, Department of Medicine, University of Alberta; Edmonton, Alberta, AB T6G 2G3, Canada.
  • Klicek F; Glycoscience Research Laboratory, Genos Ltd., Borongajska cesta 83H, 10000 Zagreb, Croatia.
  • Lauc G; Glycoscience Research Laboratory, Genos Ltd., Borongajska cesta 83H, 10000 Zagreb, Croatia.
  • Tighe P; Glycoscience Research Laboratory, Genos Ltd., Borongajska cesta 83H, 10000 Zagreb, Croatia.
  • Mullish BH; Glycoscience Research Laboratory, Genos Ltd., Borongajska cesta 83H, 10000 Zagreb, Croatia.
  • Blanco JM; Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
  • McDonald JAK; School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
  • Marchesi JR; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
  • Xue N; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
  • Dottorini T; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
  • Acharjee A; MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London SW7 2AZ, UK.
  • Franke A; Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, UK.
  • Li Y; School of Veterinary Medicine and Science, University of Nottingham, Nottingham NG7 2UH, UK.
  • Wong GK; School of Veterinary Medicine and Science, University of Nottingham, Nottingham NG7 2UH, UK.
  • Polytarchou C; College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, Centre for Computational Biology, University of Birmingham, Birmingham B15 2TT, UK.
  • Yau TO; Institute of Clinical Molecular Biology, Universitätsklinikum Schleswig-Holstein, Christian-Albrecht University of Kiel, 24105 Kiel, Germany.
  • Christodoulou N; Shenzhen Digital Life Institute, Shenzhen 518016, China.
  • Hatziapostolou M; Department of Biological Sciences, Department of Medicine, University of Alberta, Edmonton, AB T6G 2E1, Canada.
  • Wang M; Department of Biosciences, John van Geest Cancer Research Centre, Centre for Health Aging and Understanding Disease, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.
  • Russell LA; Department of Biosciences, John van Geest Cancer Research Centre, Centre for Health Aging and Understanding Disease, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.
  • Kao DH; Department of Biosciences, John van Geest Cancer Research Centre, Centre for Health Aging and Understanding Disease, School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.
Cells ; 10(11)2021 11 19.
Article em En | MEDLINE | ID: mdl-34831456
ABSTRACT
Fecal microbiota transplantation (FMT) is highly effective in recurrent Clostridioides difficile infection (CDI); increasing evidence supports FMT in severe or fulminant Clostridioides difficile infection (SFCDI). However, the multifactorial mechanisms that underpin the efficacy of FMT are not fully understood. Systems biology approaches using high-throughput technologies may help with mechanistic dissection of host-microbial interactions. Here, we have undertaken a deep phenomics study on four adults receiving sequential FMT for SFCDI, in which we performed a longitudinal, integrative analysis of multiple host factors and intestinal microbiome changes. Stool samples were profiled for changes in gut microbiota and metabolites and blood samples for alterations in targeted epigenomic, metabonomic, glycomic, immune proteomic, immunophenotyping, immune functional assays, and T-cell receptor (TCR) repertoires, respectively. We characterised temporal trajectories in gut microbial and host immunometabolic data sets in three responders and one non-responder to sequential FMT. A total of 562 features were used for analysis, of which 78 features were identified, which differed between the responders and the non-responder. The observed dynamic phenotypic changes may potentially suggest immunosenescent signals in the non-responder and may help to underpin the mechanisms accompanying successful FMT, although our study is limited by a small sample size and significant heterogeneity in patient baseline characteristics. Our multi-omics integrative longitudinal analytical approach extends the knowledge regarding mechanisms of efficacy of FMT and highlights preliminary novel signatures, which should be validated in larger studies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_zoonosis Assunto principal: Infecções por Clostridium / Transplante de Microbiota Fecal Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cells Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_zoonosis Assunto principal: Infecções por Clostridium / Transplante de Microbiota Fecal Tipo de estudo: Observational_studies / Prognostic_studies Limite: Aged / Aged80 / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cells Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
...